Independent Relations of Left Ventricular Structure With the 24-Hour Urinary Excretion of Sodium and Aldosterone
xperimental research in rats supports the hypothesis that dietary sodium intake might play a role in the pathogenesis of left ventricular hypertrophy. [1] [2] [3] Most, 4 -6 albeit not all, 7 studies in hypertensive patients noticed a significant association between left ventricular mass (LVM) and the urinary sodium excretion. However, in the Framingham Heart Study, 8 the association between LVM and the urinary sodium concentration indexed to creatinine was not significant. Furthermore, several studies in hypertensive patients 9 -11 or in populations 12, 13 observed a positive association between LVM and either circulating 9 -13 or urinary 14 aldosterone. To our knowledge, none of the previous studies addressed the association between LVM and aldosterone, while accounting for urinary sodium excretion as index of salt intake, or vice versa.
Measuring the clearance of endogenous lithium allows estimating sodium handling in the proximal and postproximal nephron. 15, 16 In an attempt to address the aforementioned inconsistencies between studies in hypertensive patients and populations, and to gain further insight in the association between LVM and aldosterone, we studied in a random sample of a white population left ventricular structure in relation to the urinary excretion of sodium and aldosterone, plasma renin activity (PRA), and renal tubular sodium handling.
Methods
The Ethics Committee of the University of Leuven approved the Flemish Study on Environment, Genes, and Health Outcomes (FLEMENGHO). 17 From August 1985 until December 2005, we recruited a random sample of families from a geographically defined area in northern Belgium. 17 We invited 652 participants for a follow-up examination, which included echocardiography; 553 gave informed written consent (participation rate, 84.8%). As described in detail in the Expanded Methods in the online Data Supplement available at http://hyper.ahajournals.org), we excluded 92 hypertensive patients on blood pressure lowering drugs and 31 women taking contraceptive pills or hormonal substitution therapy, because of the potential influence on LVM, PRA, aldosterone, or renal sodium handling. Furthermore, we excluded 48 patients with cardiac disorders, and 65 subjects because a high-quality echocardiogram (nϭ26) or the endogenous lithium clearance (nϭ39) was unavailable. Thus, the number of subjects statistically analyzed totaled 317.
One experienced observer performed all echocardiograms according to the recommendations of the American Society of Echocardiography, 18 using a Vivid 7 Pro (GE Vingmed) interfaced with a 2.5 MHz phased-array probe. All recordings were digitally stored for offline analyses. The blood pressure during echocardiography, used in adjusted analyses, was the average of 2 readings. We followed current guidelines, 18 as described in detail in the online Data Supplement, to measure the left ventricular internal diameter (LVID) and mean wall thickness (MWT), and to calculate LVM, left ventricular mass index (LVMI), and relative wall thickness (RWT). We averaged 3 cardiac cycles for statistical analysis. The intraobserver intrasession variability of LVM was 4.3%.
Trained nurses administered a questionnaire to collect information about the participants' recent medical history, smoking and drinking habits, and intake of medications. Hypertension was a clinic blood pressure of at least 140 mm Hg systolic or 90 mm Hg diastolic. Body mass index was weight in kilograms divided by the square of height in meters. Waist and hip circumferences were measured to the nearest centimeter.
On the day of the echocardiographic examinations, after the subjects had rested in supine position for at least 45 minutes, venous blood samples were drawn to measure the serum concentration of sodium, lithium, creatinine, and PRA. The participants also collected a timed 24-hour urine sample for the measurement of sodium, potassium, creatinine, and aldosterone. We determined PRA and urinary aldosterone concentration by radioimmunoassay. Electrolytes in urine and plasma were determined by flame photometry. Endogenous trace lithium was measured in serum and urine with an electrothermal atomic absorption spectrophotometer with a HGA-700 graphite furnace.
We computed the fractional excretion of sodium (FE Na ) and lithium (FE Li ) by dividing the sodium and lithium clearances by the creatinine clearance. We expressed these ratios as a percentage. The fractional proximal sodium reabsorption (RNa prox ) was defined as 100ϪFE Li . Fractional distal reabsorption of sodium (RNa dist ) was estimated as [(FE Li ϪFE Na )/FE Li ]ϫ100. RNa dist is a measure of the amount of sodium that escapes reabsorption in the proximal tubules and is reabsorbed in the postproximal tubules. 16, 19 We used SAS software (SAS Institute) version 9.1.3 for statistical analysis. We normalized the distributions of PRA and the urinary aldosterone excretion by a logarithmic transformation. We compared means and proportions, using ANOVA with Dunnett's adjustment of the significance level and the 2 statistic, respectively. Our statistical methods also included single and multiple linear regressions. We included in our models covariables with known physiological relevance 12, 20 for left ventricular structure. We additionally searched for possible covariables, using stepwise multiple regressions with the probability value for independent variables to enter and stay in the model set at 0.15. We standardized RNa dist to the mean sodium excretion rate of the whole study population (7.1 mmol/h), because there is a linear correlation between RNa dist and urinary sodium excretion. 16, 19 We applied a generalization of the standard linear model, as implemented in the PROC MIXED procedure of the SAS package, to investigate the associations between the echocardiographic measurements and explanatory variables, while accounting for relatedness among study participants and adjusting for covariables. We expressed multivariable-adjusted effect sizes for 1-SD increases in the explanatory variables.
Results

Characteristics of the Participants
The study population consisted of 317 subjects, of whom 143 (45.1%) were female and 67 (21.1%) had hypertension. Table 2 lists the echocardiographic variables by sex-specific quartiles of the 24-hour urinary excretion of sodium. In these unadjusted analyses, LVM, LVMI, and MWT (PՅ0.011) increased with higher urinary sodium excretion.
The online Data Supplement lists the characteristics of the participants (Table S1 ), including left ventricular structure (Table S2) , by sex-specific quartiles of the 24-hour aldosterone excretion. PRA and RNa dist increased with higher aldosterone excretion, whereas the opposite was true for FE Na (Table S1 ). Furthermore, LVID was positively associated with aldosterone excretion (Table S2) .
Multivariable-Adjusted Analyses
Adjusted analyses (Table 3) accounted for sex, age, body weight and height (not applicable to LVMI), systolic blood pressure, and the waist-to-hip ratio. With these adjustments applied, a 1-SD increase in the 24-hour urinary sodium excretion was associated with increases in LVMI and MWT, amounting to 2.39 g/m 2 (Pϭ0.007) and 0.111 mm (Pϭ0.081). For a 1-SD increase in the 24-hour urinary aldosterone excretion, LVMI and LVID increased by 2.58 g/m 2 (Pϭ0.005) and 0.53 mm (Pϭ0.018), respectively. There was no association between LV structure and PRA (PՆ0.21) or RNa prox (PՆ0.47). A 1-SD increase in RNa dist tended to be associated with opposite trends in LVID (ϩ0.38 mm; Pϭ0.068) and MWT (Ϫ0.108 mm; Pϭ0.069), which resulted in a significant decrease of RWT (Ϫ0.81ϫ10 Ϫ2 ; Pϭ0.018), but no change in LVMI (Pϭ0.96).
In fully adjusted models with sodium excretion or RNa dist as the explanatory variables, we introduced aldosterone excretion as an additional covariable. In models with urinary aldosterone as the explanatory variable, we entered sodium excretion as an additional covariable. These fully adjusted models were confirmatory ( In sensitivity analyses, fully adjusted as in Table 3 , we first narrowed the age range to the 10th to 90th percentile interval (28 to 66 years; nϭ254), or to the interquartile range (40 to 58 years; nϭ158). Next, we excluded 67 (21.1%) patients with hypertension or 35 (11.0%) patients with body mass index of 30 kg/m 2 or higher. As shown in the online Data Supplement (Tables S3 through S5 ), these sensitivity analyses resulted in effect sizes, which were consistent with the fully adjusted estimates in Table 3 . Furthermore, we considered serum potassium (only for models involving aldosterone) and heart rate, 12 current smoking, 12 alcohol intake, and serum creatinine (for all models), as additional covariables to be added to the fully adjusted models. These cumulative adjustments did not influence the associations of LVMI, LVID, and MWT with the 24-hour urinary excretion of sodium ( Figure 1 ) or aldosterone ( Figure 2 ). Finally, multivariable-adjusted models in which systolic blood pressure was replaced by diastolic blood pressure did not materially alter our results.
Discussion
The key finding of our study was that while accounting for covariables, LVMI independently increased with the 24-hour urinary excretion of both sodium and aldosterone. Increased MWT explained the association of LVMI with urinary sodium and increased LVID the association of LVMI with urinary aldosterone. There were no significant associations of left ventricular structure with RNa prox and PRA. Values are meanϮSD, geometric mean (interquartile range), or No. of subjects (%). PRA indicates plasma renin activity. To convert PRA to ng/ml/h, multiply by 3.6; to convert creatinine clearance to mL/min, multiply by 60. FE Na indicates the fractional excretion of sodium. RNa prox represents the fractional sodium reabsorption along the proximal tubules. RNa dist is the calculated reabsorption of sodium in the postproximal tubules. P values derived by ANOVA are for the differences across quartiles. Significance of the difference with the lowest quartile: *PՅ0.05; †PՅ0.01; ‡PՅ0.001 (adjusted for multiple comparisons by Dunnett's method).
Previous studies on the association of LVM or LVMI with urinary sodium or salt intake produced inconsistent results, because of differences in sample size, selection of subjects, background treatment, the assessment of sodium intake, the average level of exposure to sodium, and inconsistent adjustment for covariables. For instance, in 642 unmedicated employees, 7 of whom 462 were hypertensive, 24-hour urinary sodium explained 1.4% of LVM (PϽ0.05). However, this weak association disappeared after adjustment for sex, age, body mass index, systolic blood pressure, and height. 7 In 2660 participants in the Framingham Heart Study, 8 the cross-sectional association between LVM and urinary sodium was not significant. However, the Framingham investigators 8 only measured sodium in a 1-hour urine sample. By and large, our current findings are in keeping with most reports, 4, 5, 21, 22 in which sodium excretion, measured in 24-hour urine samples, was as high as in the present study.
LVMI is calculated from MWT and LVID, using an anatomically validated formula. 23 In line with previous reports, 5,21 we did not find significant association between LVID and urinary sodium excretion in adjusted analyses. However, MWT increased by approximately 0.1 mm per SD increase in sodium excretion independent of aldosterone and other covariables. We can only speculate about the underlying mechanisms. Salt-sensitive hypertensive patients on a high sodium intake have an enhanced pressure response to norepinephrine and angiotensin II, and an increased catecholamine concentration in serum and urine. Increased sympa- For explanation of abbreviations, see Tables 1 and 2 . Effect sizes are expressed for a 1-SD increase in the explanatory variables (70 mmol for sodium, and 0.24 for aldosterone on the logarithmic scale, and 5.4% for RNa dist ) and were adjusted for sex, age, body wt and height (not applicable to LVMI), systolic blood pressure, and the waist-to-hip ratio. For sodium and RNa dist , fully adjusted models included urinary aldosterone excretion. For aldosterone, fully adjusted models included urinary sodium excretion.
thetic tone, along with the raised blood pressure, could favor the onset of left ventricular hypertrophy. High sympathetic tone might also counteract the renin system inhibition in response to a high-salt diet and lead to insufficient suppression of angiotensin II.
Several studies 9 -13,24,25 reported associations between left ventricular structure and circulating or urinary aldosterone, but did not account for salt intake or sodium excretion. However, most studies addressing the association between left ventricular structure and circulation aldosterone had methodological shortcomings, because of selective recruitment of hypertensive patients, 10,11 small sample size (Ͻ120 patients, 10, 11 or minimal (only blood pressure, 25 sometimes combined with age or body mass index 13 ) or no adjustment for cofounders. Moreover, in 2 reports, 10,12 the positive association between LVM and circulating aldosterone was only observed in subgroup analyses. In the Framingham Heart Study, 12 this association was only present in women. In El-Gharbawy's study, 10 the positive correlation between LVM and plasma aldosterone was confined to obese black patients (body mass index Ն27 kg/m 2 ) and not present in lean black subjects or in whites, irrespective of their body mass index. The cut-off limit for obesity in this study did not comply with the thresholds for overweight (25 kg/m 2 ) and obesity (30 kg/m 2 ), which are usually applied in the literature. 
MWT (mm)
Urinary Sodium Excretion (mmol/24 h) Figure 1 . Scatterplots of left ventricular mass index (LVMI), left ventricular end-diastolic diameter (LVID), and mean wall thickness (MWT) vs the 24-hour urinary sodium excretion in multivariable-adjusted analyses. The full and dotted lines represent the regression line and the 95% confidence interval, respectively. The regression slopes were standardized to the distribution in all 317 subjects (mean or ratio) of sex, age, body weight and height (not applicable to LVMI), systolic blood pressure, the waist-to-hip ratio, pulse rate, current smoking, alcohol intake, serum creatinine, and the urinary aldosterone excretion. 
Urinary Aldosterone Excretion (nmol/24 h) Figure 2 . Scatterplots of left ventricular mass index (LVMI), left ventricular end-diastolic diameter (LVID), and mean wall thickness (MWT) vs the 24-hour urinary aldosterone excretion in multivariable-adjusted analyses. The full and dotted lines represent the regression line and the 95% confidence interval, respectively. The regression slopes were standardized to the distribution in all 317 subjects (mean or ratio) of sex, age, body weight, and height (not applicable to LVMI), systolic blood pressure, the waist-to-hip ratio, pulse rate, current smoking, alcohol intake, serum creatinine, serum potassium, and the urinary sodium excretion.
Furthermore, the concentration of aldosterone in the blood shows a strong diurnal profile, peaking in the early morning. The 24-hour urinary aldosterone excretion therefore provides a better estimate of the integrated daily exposure to aldosterone than the circulating aldosterone. Only 2 previous studies reported a positive association between LVM and the 24-hour urinary aldosterone excretion, but had a small sample size, involving 76 healthy white men 14 or 31 hypertensive men and 26 normotensive controls. 24 The reported associations were unadjusted in 1 study 14 and minimally adjusted for only blood pressure in the other. 24 In contrast with other population studies, 12, 13 we did not find a positive and independent correlation between MWT and aldosterone. However, the correlations in these studies were with the plasma aldosterone. Experimental studies 26, 27 suggested that aldosterone might be synthesized by the heart and that aldosterone might locally promote cardiac fibrosis. For now, the evidence remains controversial in animals 28 -30 as well as in human 31 studies. Indeed, several reports showed that in the absence of heart failure aldosterone synthase is not expressed in the heart of rats 29, 30 or humans. 31 Messenger RNA coding for 2 rate-limiting enzymes in the biosynthesis of aldosterone is 1000 to 10 000 less abundant in the heart than in the adrenal zona glomerulosa. 29 The correlation of urinary sodium excretion with aldosterone output in urine was negative, as expected, but probably because of the high variability in both measurements, it did not reach statistical significance. Aldosterone reduces sodium excretion by stimulating sodium reabsorption in the distal tubule and the collecting duct. These are the main nephron segments, where sodium reabsorption is adjusted to maintain excretion at a level appropriate for the dietary intake. In our study, before and after adjustment, RNa dist was positively correlated with the 24-hour urinary aldosterone excretion. This observation is consistent with the physiological role of aldosterone and represents a validation of our current findings. The increased cardiac preload, attributable to an increased proportional reabsorption of both sodium and water in the postproximal tubules, might contribute to the currently observed association of LVMI and LVID with aldosterone.
Increased dietary salt intake normally suppresses the reninangiotensin-aldosterone system. However, in our data, the association between urinary sodium excretion and the log transformed PRA was very weak. Many factors influence PRA. Indeed, upright posture stimulates PRA, whereas PRA decreases with higher blood pressure and more advanced age. In addition to antihypertensive medications, PRA is also under influence of the menstrual cycle in women at reproductive age. Moreover, PRA has a strong diurnal profile. We excluded hypertensive patients on blood pressure lowering drugs and women taking contraceptive pills or hormonal substitution therapy. Blood samples were taken after 45 minutes supine rest; however, we could not standardize for the time of day, at which the blood was taken. In women of reproductive age, we did not record the day of the menstrual cycle.
Our study has to be interpreted within the context of its limitations and strengths. First, in comparison with other population studies, 8, 12 our sample size was relatively small. Second, LVM is a quantitative trait prone to measurement error. However, only 1 experienced observer performed all ultrasound examinations. We excluded patients with overt heart diseases that change cardiac structure. Third, in subjects with a randomly fluctuating intake of sodium, a single 24-hour urine collection might be insufficient to characterize an individual's habitual sodium intake, 32 but it certainly gives a better estimate of salt intake than overnight 6 or even shorter 8 urine collections do. Variability in the urinary measurements would weaken rather than produce correlations. Finally, in previous studies, 9,11-13 the circulating aldosterone concentration was measured at a single time of day, whereas we assessed the integrated daily production of aldosterone from its excretion.
Perspectives
Our population study was the first to address the relation between LVMI and the 24-hour urinary excretion of both sodium and aldosterone. Both measurements were associated with LVMI, but via different pathways. Increased wall thickness explained the association of LVMI with urinary sodium and increased LVID explained the association of LVMI with urinary aldosterone. If confirmed, the hormonal, paracrine, autonomous nervous, and molecular machinery underlying these differential pathways needs to be unraveled.
Expanded Methods
Study Population
The Ethics Committee of the University of Leuven approved the Flemish Study on Environment, Genes and Health Outcomes (FLEMENGHO). 1 From August 1985 until December 2005, we recruited a random sample of families from a geographically defined area in northern Belgium. 1 We invited 652 participants for a follow-up examination, which included echocardiography; 553 gave informed written consent (participation rate, 84.8%). For the present study, we excluded 92 hypertensive patients on blood pressure lowering drugs and 31 women taking contraceptive pills or hormonal substitution therapy, because of the potential influence on left ventricular mass (LVM), plasma renin activity (PRA), aldosterone, and renal sodium handling. Furthermore, we excluded 113 subjects because a high-quality echocardiogram was unavailable (n=26), because the endogenous lithium clearance had not been measured (n=22), because the lithium concentration in serum (≥1.0 umol/L) or urine (≥20 umol/L) was suggestive of external contamination (n=5), because the indexes of renal sodium handling were more than 3 standard deviations away from the mean (n=12), or because of cardiac disorders (n=48). Thus, the number of subjects statistically analyzed totaled 317.
Echocardiography
The participants refrained from smoking, heavy exercise, and drinking alcohol or caffeinecontaining beverages for at least 3 h before echocardiography. One experienced observer performed all echocardiograms according to the recommendations of the American Society of Echocardiography, 2 using a Vivid 7 Pro (GE Vingmed, Horten, Norway) interfaced with a 2.5 MHz phased-array probe. All recordings were digitally stored for off-line analyses. The blood pressure during echocardiography, used in adjusted analyses, was the average of two readings, obtained at the end of the examination with a validated 3 OMRON 705IT device (Omron Corp., Tokyo Japan).
Left ventricular internal diameter (LVID) and interventricular septal and posterior wall thickness at end-diastole were measured according to current guidelines. 2 Mean wall thickness (MWT) was the sum of the interventricular septal and posterior wall thickness at end-diastole divided by two. We calculated LVM by an anatomically validated formula 4 
Clinical Measurements
Trained nurses measured the subjects' anthropometric characteristics. They administered a questionnaire to collect information about the participants' recent medical history, smoking and drinking habits, and intake of medications. Each subject's clinic blood pressure was the average of five consecutive auscultatory readings (phase V diastolic blood pressure) measured at the examination center after at least five minutes of sitting rest. Hypertension was a blood pressure of at least 140 mm Hg systolic or 90 mm Hg diastolic. Body mass index was weight in kilograms divided by the square of height in meters. Waist and hip circumferences were measured to the nearest centimeter.
Renal Sodium Handling
On the day of the echocardiographic examinations, after the subjects had rested in supine position for at least 45 min, venous blood samples were drawn to measure the serum concentration of sodium, lithium, creatinine and PRA. The participants also collected a timed 24-h urine sample in a wide-neck plastic container for the measurement of sodium, potassium, creatinine and aldosterone. We determined PRA (RIA-0180; DRG Instruments GmbH, Marburg an der Lahn, Germany) and urinary aldosterone concentration (DSL-8600 Active; Diagnostic Systems Laboratories Inc., Webster, TX, USA) by radioimmunoassay. Electrolytes in urine and plasma were determined by flame photometry. Endogenous trace lithium was measured in serum and urine with an electrothermal atomic absorption spectrophotometer (model AAS 300) with a HGA-700 graphite furnace (Perkin-Elmer Inc., Boston, MA). 5 Clearances (C) were calculated as C x = U x × V/P x , where U x and P x are the urinary and plasma concentrations of the solute x, and V is the urine flow in mL/min. We computed the fractional excretion of sodium (FE Na ) and lithium (FE Li ) by dividing the sodium and lithium clearances by the creatinine clearance. We expressed these ratios as a percentage. The fractional proximal sodium reabsorption (RNa prox ) was defined as 100 - 
Statistical Analysis
We used SAS software (SAS Institute, Cary, NC), version 9.1.3 for statistical analysis. We normalized the distributions of PRA and the urinary aldosterone excretion by a logarithmic transformation. We compared means and proportions, using ANOVA with Dunnett's adjustment of the significance level and the χ 2 -statistic, respectively. Our statistical methods also included single and multiple linear regressions. We included in our models covariables with known physiologic relevance 8, 9 for left ventricular structure: sex, age, body weight and height (not applicable to LVMI), systolic blood pressure and the waist-to-hip ratio. We additionally searched for possible covariables, using stepwise multiple regressions with the P-value for independent variables to enter and stay in the model set at 0.15. We standardized RNa dist to the mean sodium excretion rate of the whole study population (7.1 mmol/h), because there is a linear correlation between RNa dist and urinary sodium excretion. 6, 7 We applied a generalization of the standard linear model, as implemented in the PROC MIXED procedure of SAS package, to investigate the associations between the echocardiographic measurements and explanatory variables, while accounting for relatedness among study participants and adjusting for covariables. We expressed multivariable-adjusted effect sizes for 1-SD increases in the explanatory variables. For explanation of abbreviations, see Table S2 . Effect sizes are expressed for a 1-SD increase in the explanatory variables (70 mmol for sodium, and 0.24 for aldosterone on the logarithmic scale), and were adjusted for sex, age, body weight and height (not applicable to LVMI), systolic blood pressure and the waist-to-hip ratio. * Analyses additionally adjusted for urinary aldosterone. † Analyses additionally adjusted for urinary sodium.
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